Sargent Bickham Lagudis’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 1037 |
|
|
2021
Q1 | $0 | Sell |
1
-47
| -98% | -$8.83K | ﹤0.01% | 1009 |
|
|
2020
Q4 | $6K | Hold |
48
| – | – | ﹤0.01% | 728 |
|
|
2020
Q3 | $5K | Buy |
48
+2
| +4% | +$230 | ﹤0.01% | 674 |
|
|
2020
Q2 | $6K | Hold |
46
| – | – | ﹤0.01% | 637 |
|
|
2020
Q1 | $4K | Buy |
46
+45
| +4,500% | +$4.76K | ﹤0.01% | 668 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 896 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 802 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 827 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 853 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 815 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 800 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 815 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 822 |
|
|
2017
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 841 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 841 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 819 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 790 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 762 |
|
|
2016
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 789 |
|
|
2016
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 775 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | +$55 | ﹤0.01% | 736 |
|
Other funds holding GWPH
Sargent Bickham Lagudis's GWPH Position: Q2 2021 in Review
Sargent Bickham Lagudis sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1 share.
Sargent Bickham Lagudis first reported a position in GWPH in Q1 2016 and held it in 21 quarters. The position peaked at $6K in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Sargent Bickham Lagudis reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Sargent Bickham Lagudis sold 1 GW Pharmaceuticals Plc American Depositary Shares share in Q2 2021.
- Sargent Bickham Lagudis first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 21 quarters.
- Sargent Bickham Lagudis's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6K in Q4 2020.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Sargent Bickham Lagudis's 13F filing for Q2 2021, filed 19 Jul 2021.